Literature DB >> 20143870

Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance.

Majida Abu Shehab1, Javad Khosravi, Victor K M Han, Brian H Shilton, Madhulika B Gupta.   

Abstract

Phosphorylation enhances IGFBP-1 binding to IGF-I, thereby limiting the bioavailability of IGF-I that may be important in fetal growth. Our goal in this study was to determine whether changes in site-specific IGFBP-1 phosphorylation were unique to fetal growth restriction. To establish a link, we compared IGFBP-1 phosphorylation (sites and degree) in amniotic fluid from FGR (N = 10) and controls (N = 12). The concentration of serine phosphorylated IGFBP-1 showed a negative correlation with birth weight in FGR (P = 0.049). LC-MS/MS analysis revealed all four previously identified phosphorylation sites (Ser98, Ser101, Ser119, and Ser169) to be common to FGR and control groups. Relative phosphopeptide intensities (LC-MS) between FGR and controls demonstrated 4-fold higher intensity for Ser101 (P = 0.026), 7-fold for Ser98/Ser101 (P = 0.02), and 23-fold for Ser169 (P = 0.002) in the FGR group. Preliminary BIAcore data revealed 4-fold higher association and 1.7-fold lower dissociation constants for IGFBP-1/IGF-I in FGR. A structural model of IGFBP-1 bound to IGF-I indicates that all the phosphorylation sites are on relatively mobile regions of the IGFBP-1 sequence. Residues Ser98, Ser101, and Ser169 are close to structured regions that are involved in IGF-I binding and, therefore, could potentially make direct contact with IGF-I. On the other hand, residue Ser119 is in the middle of the unstructured linker that connects the N- and C-terminal domains of IGFBP-1. The model is consistent with the assumption that residues Ser98, Ser101, and Ser169 could directly interact with IGF-I, and therefore phosphorylation at these sites could change IGF-I interactions. We suggest that site-specific increase in IGFBP-1 phosphorylation limits IGF-I bioavailability, which directly contributes to the development of FGR. This study delineates the potential role of higher phosphorylation of IGFBP-1 in FGR and provides the basis to substantiate these findings with larger sample size.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143870     DOI: 10.1021/pr900987n

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  14 in total

1.  Hyperphosphorylation of fetal liver IGFBP-1 precedes slowing of fetal growth in nutrient-restricted baboons and may be a mechanism underlying IUGR.

Authors:  Jenica H Kakadia; Bhawani B Jain; Kyle Biggar; Austen Sutherland; Karen Nygard; Cun Li; Peter W Nathanielsz; Thomas Jansson; Madhulika B Gupta
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-03       Impact factor: 4.310

2.  The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Madhulika B Gupta
Journal:  J Cell Commun Signal       Date:  2015-02-15       Impact factor: 5.782

3.  Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.

Authors:  Ian Damerill; Kyle K Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Endocrinol       Date:  2015-12-29

4.  Co-Localization of Insulin-Like Growth Factor Binding Protein-1, Casein Kinase-2β, and Mechanistic Target of Rapamycin in Human Hepatocellular Carcinoma Cells as Demonstrated by Dual Immunofluorescence and in Situ Proximity Ligation Assay.

Authors:  Sahil S Singal; Karen Nygard; Manthan R Dhruv; Kyle Biggar; Majida A Shehab; Shawn S-C Li; Thomas Jansson; Madhulika B Gupta
Journal:  Am J Pathol       Date:  2017-10-14       Impact factor: 4.307

Review 5.  Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth†.

Authors:  Madhulika B Gupta; Thomas Jansson
Journal:  Biol Reprod       Date:  2019-04-01       Impact factor: 4.285

6.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Majida Abu Shehab; Ian Damerill; Tong Shen; Fredrick J Rosario; Mark Nijland; Peter W Nathanielsz; Amrita Kamat; Thomas Jansson; Madhulika B Gupta
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

7.  Exposure of decidualized HIESC to low oxygen tension and leucine deprivation results in increased IGFBP-1 phosphorylation and reduced IGF-I bioactivity.

Authors:  Majida Abu Shehab; Kyle Biggar; Sahil Sagar Singal; Karen Nygard; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2017-04-21       Impact factor: 4.102

8.  Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.

Authors:  Niyati Malkani; Kyle Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2015-12-28       Impact factor: 4.102

9.  Maternal nutritional history modulates the hepatic IGF-IGFBP axis in adult male rat offspring.

Authors:  Timothy Smith; Deborah M Sloboda; Richard Saffery; Eric Joo; Mark H Vickers
Journal:  Endocrine       Date:  2013-08-21       Impact factor: 3.633

10.  Effects of maternal nutrient restriction, intrauterine growth restriction, and glucocorticoid exposure on phosphoenolpyruvate carboxykinase-1 expression in fetal baboon hepatocytes in vitro.

Authors:  Cun Li; Zhen-Ju Shu; Shuko Lee; Madhulika B Gupta; Thomas Jansson; Peter W Nathanielsz; Amrita Kamat
Journal:  J Med Primatol       Date:  2013-04-20       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.